SCHEMBL9985676

SCHEMBL9985676

CC(C)(C)[Si](C)(C)O[C@H]1CCCC(O)C1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPM1D O15297 2/20 0.38
CNR2 P34972 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5711228 1.00 PPM1D (0.38) PPM1DCNR2
SCHEMBL660447 1.00 PPM1D (0.38) PPM1DCNR2
SCHEMBL5711230 1.00 PPM1D (0.38) PPM1DCNR2
SCHEMBL25382185 0.96 PPM1D (0.35) PPM1D
SCHEMBL661089 0.89 PPM1D (0.34) PPM1D
SCHEMBL5831542 0.89 PPM1D (0.34) PPM1D
SCHEMBL20758481 0.89 PPM1D (0.34) PPM1D
SCHEMBL360950 0.89 PPM1D (0.36) PPM1D
SCHEMBL1015667 0.89 PPM1D (0.34) PPM1D
SCHEMBL18535817 0.89 PPM1D (0.34) PPM1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585444-A1 AZASPIROHEXANONES AS INHIBITORS OF 11-BETA-HSD1 FOR THE TREATMENT OF METABOLIC DISORDERS Boehringer Ingelheim International GmbH (DE) 2013-05-01 EP disclosed
WO-2011161128-A1 AZASPIROHEXANONES AS INHIBITORS OF 11-BETA-HSD1 FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-29 WO disclosed
EP-1773791-B1 PYRROLOTRIAZINE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2010-09-22 EP disclosed